Literature DB >> 21147064

Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori.

Hitoshi Tsugawa1, Hidekazu Suzuki, Hiroe Muraoka, Fumiaki Ikeda, Kenro Hirata, Juntaro Matsuzaki, Yoshimasa Saito, Toshifumi Hibi.   

Abstract

Although metronidazole (Mtz) is an important component of Helicobacter pylori eradication regimens, it has been pointed out that the increasing use of Mtz may result in increase in the incidence of Mtz-resistant strains. The present study was designed to examine the initial mechanism of resistance acquisition of H. pylori to Mtz. After 10 Mtz-susceptible strains were cultured on plates containing sub-inhibitory concentrations of Mtz, the MIC of Mtz for 9 of the 10 strains increased to levels of the Mtz-resistant strains. In the Mtz-resistance-induced strains, the expression of the TolC efflux pump (hefA) was significantly increased under Mtz exposure, without the reduction of the Mtz-reductive activity. Our finding suggests that overexpression of hefA may be the initial step in the acquisition of Mtz resistance in H. pylori. Copyright
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147064     DOI: 10.1016/j.bbrc.2010.12.034

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Hitoshi Tsugawa; Hiroe Muraoka; Juntaro Matsuzaki; Kenro Hirata; Fumiaki Ikeda; Masahiko Takahashi; Toshifumi Hibi
Journal:  Antimicrob Agents Chemother       Date:  2011-04-12       Impact factor: 5.191

Review 3.  Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Authors:  Evariste Tshibangu-Kabamba; Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

4.  Polysorbate 80 and Helicobacter pylori: a microbiological and ultrastructural study.

Authors:  Natale Figura; Roberto Marcolongo; Giovanni Cavallo; Annalisa Santucci; Giulia Collodel; Adriano Spreafico; Elena Moretti
Journal:  BMC Microbiol       Date:  2012-09-22       Impact factor: 3.605

5.  Nordihydroguaiaretic Acid Disrupts the Antioxidant Ability of Helicobacter pylori through the Repression of SodB Activity In Vitro.

Authors:  Hitoshi Tsugawa; Hideki Mori; Juntaro Matsuzaki; Tatsuhiro Masaoka; Tasuku Hirayama; Hideko Nagasawa; Yasubumi Sakakibara; Makoto Suematsu; Hidekazu Suzuki
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

6.  Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.

Authors:  Patrick M Chong; Tarah Lynch; Stuart McCorrister; Pamela Kibsey; Mark Miller; Denise Gravel; Garrett R Westmacott; Michael R Mulvey
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

7.  Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.

Authors:  Tarah Lynch; Patrick Chong; Jason Zhang; Romeo Hizon; Tim Du; Morag R Graham; Daniel R Beniac; Timothy F Booth; Pamela Kibsey; Mark Miller; Denise Gravel; Michael R Mulvey
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

8.  RND multidrug efflux pumps: what are they good for?

Authors:  Carolina Alvarez-Ortega; Jorge Olivares; José L Martínez
Journal:  Front Microbiol       Date:  2013-02-05       Impact factor: 5.640

9.  Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes.

Authors:  Akira Iwamoto; Toshihito Tanahashi; Rina Okada; Yukio Yoshida; Kaoru Kikuchi; Yoshihide Keida; Yoshiki Murakami; Lin Yang; Koji Yamamoto; Shin Nishiumi; Masaru Yoshida; Takeshi Azuma
Journal:  Gut Pathog       Date:  2014-06-26       Impact factor: 4.181

Review 10.  Multidrug Efflux Systems in Microaerobic and Anaerobic Bacteria.

Authors:  Zeling Xu; Aixin Yan
Journal:  Antibiotics (Basel)       Date:  2015-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.